| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-12 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Sale | -10,000 | -8.05%114,287.874 | $241.15 | $2,411,500 | View SEC filing | |
| 2026-03-03 | Decker Robert J VP Corporate Controller | Sale | -4,075 | -14.68%23,682 | $247.87 | $1,010,070 | View SEC filing | |
| 2026-02-23 | Schmid Timothy EVP, WW Chair, MedTech | Sale | -1,322 | -4.94%25,447 | $245.66 | $324,763 | View SEC filing | |
| 2026-02-18 | Swanson James D. EVP, CIO | Sale | -62,080 | -42.11%25,698.131 | $243.39 | $15,109,759 | View SEC filing | |
| 2026-02-18 | Wolk Joseph J Exec VP, CFO | Sale | -89,654 | -75.95%14,000 | $242.80 | $21,767,827 | View SEC filing | |
| 2026-02-18 | REED JOHN C EVP, Innovative Medicine, R&D | Sale | -53,931 | -69.25%10,658 | $243.00 | $13,105,233 | View SEC filing | |
| 2026-02-18 | Schmid Timothy EVP, WW Chair, MedTech | Sale | -22,623 | -33.73%26,769 | $244.33 | $5,527,506 | View SEC filing | |
| 2026-02-18 | Broadhurst Vanessa EVP, Global Corp Affairs | Sale | -6,197 | -21.22%23,003 | $243.39 | $1,508,288 | View SEC filing | |
| 2026-01-28 | Duato Joaquin CEO and Chairman of the Board | Sale | -100,000 | -76.42%30,852 | $221.23 | $22,122,893 | View SEC filing | |
| 2025-12-01 | MORIKIS JOHN G Director | Purchase | +1,250 | +208.85%1,848.51 | $206.15 | $257,688 | View SEC filing | |
| 2025-10-20 | REED JOHN C EVP, Innovative Medicine, R&D | Sale | -21,721 | -67.08%10,658 | $192.71 | $4,185,793 | View SEC filing | |
| 2025-09-05 | Taubert Jennifer L EVP, WWC. Innovative Medicine | Sale | -56,471 | -24.08%178,013.001 | $177.81 | $10,040,883 | View SEC filing | |
| 2025-08-25 | Duato Joaquin CEO and Chairman of the Board | Sale | -125,824 | -31.32%275,967 | $179.21 | $22,548,655 | View SEC filing | |
| 2025-08-18 | Wolk Joseph J Exec VP, CFO | Sale | -16,820 | -54.57%14,000 | $176.91 | $2,975,571 | View SEC filing | |
| 2025-07-18 | REED JOHN C EVP, Innovative Medicine, R&D | Sale | -19,137 | -64.23%10,658 | $163.55 | $3,129,830 | View SEC filing | |
| 2025-02-26 | Decker Robert J VP Corporate Controller | Sale | -6,999 | -25.00%21,001 | $165.88 | $1,160,994 | View SEC filing | |
| 2025-02-18 | Schmid Timothy EVP, WW Chair, MedTech | Sale | -403 | -2.60%15,098 | $156.15 | $62,928 | View SEC filing | |
| 2025-02-11 | Wolk Joseph J Exec VP, CFO | Sale | -13,015 | -100.00%0 | $153.89 | $2,002,878 | View SEC filing | |
| 2024-12-12 | WEINBERGER MARK A Director | Purchase | +1,000 | +100.00%1,000 | $147.22 | $147,220 | View SEC filing | |
| 2024-09-03 | Decker Robert J VP Corporate Controller | Sale | -5,635 | -22.90%18,973 | $165.06 | $930,113 | View SEC filing | |
| 2024-03-13 | Broadhurst Vanessa EVP, Global Corp Affairs | Sale | -8,891 | -37.15%15,043 | $162.16 | $1,441,765 | View SEC filing | |
| 2024-02-12 | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals | Sale | -59,397 | -29.58%141,416.001 | $156.27 | $9,281,969 | View SEC filing | |
| 2023-07-27 | Fasolo Peter Exec VP, Chief HR Officer | Sale | -20,000 | -16.30%102,696.006 | $170.32 | $3,406,498 | View SEC filing | |
| 2023-07-27 | Hait William See Remarks | Sale | -14,698 | -14.35%87,747 | $172.00 | $2,528,056 | View SEC filing | |
| 2023-06-14 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Sale | -12,465 | -15.90%65,933.874 | $160.00 | $1,994,400 | View SEC filing |
1-25 of 206
